发明名称 Methods and compositions for the treatment of symptoms of prion diseases
摘要 A therapeutic composition for the treatment of the symptoms of prion diseases and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. The therapeutic composition may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic composition may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as a biomarker for the presence of a prion disease, or the likelihood of an individual to develop a prion disease is disclosed.
申请公布号 US9061033(B2) 申请公布日期 2015.06.23
申请号 US201313737225 申请日期 2013.01.09
申请人 CUREMARK LLC 发明人 Fallon Joan M.
分类号 A61K38/54;A61K38/47;C12Q1/37;G01N33/68;A61K38/46;A61K38/48;A61K36/185 主分类号 A61K38/54
代理机构 Wilson Sonsini Goodrich & Rosati, P.C. 代理人 Wilson Sonsini Goodrich & Rosati, P.C.
主权项 1. A method for treating one or more symptoms of a prion disease in a patient diagnosed with the prion disease, the method comprising administering to the patient a therapeutically effective amount of a pharmaceutical composition consisting essentially of a mixture of digestive enzymes the mixture comprising at least a protease, an amylase, and a lipase, whereby one or more symptoms of the prion disease is treated; wherein said patient diagnosed with the prion disease has a subnormal level of fecal chymotrypsin.
地址 Rye NY US